Comparison of the Usefulness of Gadodiamide and Iodine Mixture Versus Iodinated Contrast Alone for Prevention of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease Undergoing Coronary Angiography

American Journal of Cardiology

Volumn 100, Issue 7, 2007, Pages 1090-1093

  Reed, Pamela S ^a   Dixon, Simon R ^a   Boura, Judith A ^a   O'Neill, William W ^b   Kahn, Joel K ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CREATININE; GADODIAMIDE; IODINATED CONTRAST MEDIUM; IODIXANOL; IOHEXOL; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY DISEASE; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CONTRAST RADIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DRUG MEGADOSE; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FEMALE; GADOLINIUM DTPA; HUMANS; INCIDENCE; IOHEXOL; IOXAGLIC ACID; KIDNEY DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRIIODOBENZOIC ACIDS;

EID: 34548621650     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.04.055     Document Type: Article

References (18)

1. McCullough P.A., and Berman A.D. Percutaneous coronary interventions in the high-risk renal patient: strategies for renal protection and vascular protection. Cardiol Clin 23 (2005) 299-310
2. Hammer F.D., Goffette P.P., Malaise J., and Mathurin P. Gadolinium dimeglumine: An alternative contrast agent for digital subtraction angiography. Eur Radiol 9 (1999) 128-136
3. Spinosa D.J., Angle J.F., Hagspiel K.D., Bissonette E., Conaway M.R., Hartwell G.D., and Matsumoto A.H. Feasibility of gadodiamide compared with dilute iodinated contrast material for imaging of the abdominal aorta and renal arteries. J Vasc Interv Radiol 11 (2000) 733-737
4. 2 and gadopentate dimeglumine as alternative contrast agents for malfunctioning dialysis grafts and fistulas. Kidney Int 54 (1998) 945-950
5. Spinosa D.J., Matsumoto A.H., Angle J.F., Hagspiel K.D., Isaacs R.B., McCullough C.S., and Lobo P.I. Gadolinium-based contrast and carbon dioxide angiography to evaluate renal transplants for vascular causes of renal insufficiency and accelerated hypertension. J Vasc Interv Radiol 9 (1998) 909-916
6. Murphy J.M., O'Hare N.J., Smiddy P., and Molloy M.P. Gadopentetate demeglumine as a contrast agent in peripheral angioplasty. Acta Radiol 39 (1998) 576-578
7. 2-enhanced renal angiography for diagnosis and percutaneous treatment. Radiology 210 (1999) 663-672
8. Nussbaum E.S., Casey S.O., Sebring L.A., and Madison M.T. Use of gadolinium as an intraarterial contrast agent in digital subtraction angiography of the cervical carotid arteries and intracranial circulation. J Neurosurg 92 (2000) 881-883
9. Sarkis A., Badaoui G., Slaba S., Moussali A., and Jebara V.A. Gadolinium-based coronary angiography in a patient with renal failure: first clinical report. Catheter Cardiovasc Interv 54 (2001) 68-69
10. Briguori C., Colombo A., Airoldi F., Melzi G., Michev I., Carlino M., Montorfano M., Chieffo A., Bellanca R., and Ricciardelli B. Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures. Catheter Cardiovasc Interv 67 (2006) 175-180
11. Prince M.R., Asrnoldus C., and Frisoli J.K. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 6 (1996) 162-166
12. Townsend R.R., Cohen D.L., Katholi R., Swan S.K., Davies B.E., Bensel K., Lanmbrecht L., and Parker J. Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency. Am J Kidney Dis 36 (2000) 1207-1212
13. Rieger J., Sitter T., Toepfer M., Linsenmaier U., Pfeifer K., and Schiffl H. Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant 17 (2002) 824-828
14. Erley C., Bader B., Berger E., Tuncel N., Winkler S., Tepe G., Risler T., and Duda S. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients. Nephrol Dial Transplant 19 (2004) 2526-2531
15. Nyman U., Elmstahl B., Leander P., Nilsson M., Golman K., and Almen T. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia?. Radiology 223 (2002) 311-318
16. McCullough P. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv 67 (2006) 335-343
17. Stacul F., Adam A., Becker C.R., Davidson C., Lameire N., McCullough P.A., and Tumlin J. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 98 suppl (2006) 59K-77K
18. Gleeson T., O'Dwyer J., Bulugahapitiya S., and Foley D. Contrast-induced nephropathy. Br J Cardiol 11 suppl (2004) AIC 53-AIC 61